Overview
Xiaobin Cui practices in Nanjing, China. Cui is rated as an Advanced expert by MediFind in the treatment of Esophageal Cancer. Their top areas of expertise are Esophageal Cancer, Synovial Sarcoma, Rhabdomyosarcoma, and Adult Soft Tissue Sarcoma.
Their clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 27 articles in the study of Esophageal Cancer.
Locations
Zhujing, 200233, China
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Esophageal CancerCui isAdvanced. Learn about Esophageal Cancer.
- Experienced
- Adult Soft Tissue SarcomaCui isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Gastroesophageal Junction Cancer
- Human Papillomavirus Infection
- RhabdomyosarcomaCui isExperienced. Learn about Rhabdomyosarcoma.
- Synovial SarcomaCui isExperienced. Learn about Synovial Sarcoma.